03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
A Texas federal court certified a class in an ERISA action brought by participants in one plan, but ...
Read More >
Given the unique characteristics of the health care space, wage and hour compliance can be particula...
Read More >
The National Labor Relations Board (NLRB) issued a whirlwind series of rulings to cap off 2019. The ...
Read More >
In a recent decision arising out of the sale of Cablevision, the Delaware Court of Chancery issued i...
Read More >
For the first time since 2014, the Department of Justice’s (DOJ) Foreign Corrupt Practices Act (FCP...
Read More >
Increased awareness of safety concerns related to foreign direct investments has prompted a ramp-up ...
Read More >